Heart Lung Machine Market Summary
The Global Heart Lung Machine Market is projected to grow from 8.78 USD Billion in 2024 to 14.4 USD Billion by 2032.
Key Market Trends & Highlights
Heart Lung Machine Key Trends and Highlights
- The market is expected to experience a compound annual growth rate (CAGR) of 4.57 percent from 2025 to 2032.
- By 2035, the market valuation is anticipated to reach 14.4 USD Billion, indicating robust growth potential.
- In 2024, the market is valued at 8.78 USD Billion, reflecting a solid foundation for future expansion.
- Growing adoption of heart lung machines due to increasing cardiovascular surgeries is a major market driver.
Market Size & Forecast
| 2024 Market Size | 8.78 (USD Billion) |
| 2035 Market Size | 14.4 (USD Billion) |
| CAGR (2025-2035) | 4.57% |
Major Players
Roche Diagnostics, LivaNova PLC, BD, Siemens Healthineers, Abbott, Stryker, Terumo Cardiovascular Systems, Medtronic, Fresenius SE KGa, HemoCue AB, Natus Medical Incorporated, Maquet, Zoll Medical Corporation, Sorin Group, Getinge AB

Leave a Comment